CYP1A1酶活性通过调控AHR通路影响皮肤炎症
该研究在小鼠和银屑病患者样本中探讨CYP1A1酶活性对AHR通路及皮肤炎症的调控作用。组成性表达Cyp1a1的小鼠皮肤中CYP1A1酶活性增加,导致免疫细胞活化和皮肤病理加重,类似Ahr缺陷小鼠;抑制CYP1A1酶活性可恢复有益AHR信号并改善免疫病理。银屑病患者AHR通路活化降低且CYP1A1酶活性升高,提示AHR/CYP1A1轴失调参与炎症性皮肤病。
要点
- CYP1A1酶活性增高加重皮肤炎症,与AHR缺陷表型相似。
- 抑制CYP1A1可恢复AHR信号并减轻皮肤免疫病理。
- 银屑病患者AHR通路活化降低且CYP1A1活性升高。
核心结论
- CYP1A1酶活性是皮肤炎症中有益AHR信号的关键调节因子,调节CYP1A1活性可能成为 harness AHR通路抗炎效应的替代策略。
研究设计与样本
- 研究使用组成性表达Cyp1a1的小鼠与Ahr缺陷小鼠进行比较,并检测银屑病患者与健康供者样本中AHR通路活化和CYP1A1酶活性。
主要发现
- 组成性表达Cyp1a1的小鼠皮肤中CYP1A1酶活性增加,导致免疫细胞活化和皮肤病理加重,与Ahr缺陷小鼠观察到的表型相似。
- 抑制CYP1A1酶活性可通过恢复有益AHR信号改善皮肤免疫病理。
- 银屑病患者与健康供者相比显示AHR通路活化降低且CYP1A1酶活性升高。
关键数值与推荐
- 银屑病患者AHR通路活化降低,CYP1A1酶活性升高(与健康供者比较)。
- 组成性表达Cyp1a1小鼠皮肤CYP1A1酶活性增加,免疫细胞活化和皮肤病理加重。
临床怎么用
- 调节CYP1A1活性可能作为激活AHR通路抗炎效应的替代策略用于炎症性皮肤病。
局限性
- 研究未报告样本量、具体统计值及详细方法学信息。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The AHR is an environmental sensor and transcription factor activated by a variety of man-made and natural ligands, which has recently emerged as a critical regulator of homeostasis at barrier organs such as the skin. Activation of the AHR pathway downmodulates skin inflammatory responses in animal models and psoriasis clinical samples. In this study, we identify CYP1A1 enzymatic activity as a critical regulator of beneficial AHR signaling in the context of skin inflammation. Mice constitutively expressing Cyp1a1 displayed increased CYP1A1 enzymatic activity in the skin, which resulted in exacerbated immune cell activation and skin pathology, mirroring that observed in Ahr-deficient mice. Inhibition of CYP1A1 enzymatic activity ameliorated the skin immunopathology by restoring beneficial AHR signaling. Importantly, patients with psoriasis displayed reduced activation of the AHR pathway and increased CYP1A1 enzymatic activity compared with healthy donors, suggesting that dysregulation of the AHR/CYP1A1 axis may play a role in inflammatory skin disease. Thus, modulation of CYP1A1 activity may represent a promising alternative strategy to harness the anti-inflammatory effect exerted by activation of the AHR pathway in the skin.
引用
- Kyoreva M, Li Y, Hoosenally M, et al. CYP1A1 Enzymatic Activity Influences Skin Inflammation Via Regulation of the AHR Pathway. J Invest Dermatol. 2020. PMID: 33385398. doi:10.1016/j.jid.2020.11.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。